Ozempic-curious people are taking a novel approach to using the blockbuster weight loss drug — and some doctors are even ...

With the third quarter of 2024 ending, the discourse on the stock market for global equities has shifted back to interest ...

In case you’ve missed it, weight-loss meds like Ozempic, Wegovy, and Mounjaro are the talk of Hollywood right now. These drugs, initially created to treat Type 2 diabetes or obesity, have taken the ...

Some oncologists are turning to GLP-1 agents to help patients shed excess pounds, with the goal of improving cancer outcomes.

On Tuesday, congressional leaders spent two hours taking to task Novo Nordisk Chief Executive Officer Lars Fruergaard Jørgensen over the high price of the company’s diabetes and obesity drugs, Ozempic ...

Two naturally occurring molecules could be the key to sustained weight management, offering an organic alternative to ...

U.S. representative from Austin asks Health and Human Services secretary to push for generic licensing of semaglutide ...

Roche said it plans to focus on five key therapeutic areas as part of its new pharma strategy through 2030. The company will prioritize work in the areas of neurology, oncology and hematology, ...

Exploding sales of prescription weight loss medications have catapulted Novo Nordisk (NVO) and Eli Lilly (LLY) to become the ...

The Center for Human Nutrition at the U of A is conducting a research study to learn more about the effects of protein on ...

Analysts at JPMorgan Chase & Co. last week flagged that Novo Nordisk’s third-quarter results in November may show slower-than ...